Vogt-Koyanagi-Harada (VKH) disease is an idiopathic, multisystem autoimmune disorder characterized by bilateral, diffuse granulomatous uveitis associated with neurological, audiovestibular, and dermatological manifestations. The purpose of this study is to investigate vestibular functions in patients with VKH disease. A total of 43 patients with VKH disease in Hokkaido University Hospital were enrolled in this study. Subjective symptoms such as dizziness or vertigo and the results of various vestibular examinations including nystagmus testing, caloric testing, and vestibular-evoked myogenic potential (VEMP) testing were investigated. Eight of 42 patients (19.0%) complained of subjective vestibular symptoms. On the other hand, 12 of 28 patients (42.9%) showed nystagmus, and 7 of 15 patients (46.7%) showed unilateral or bilateral weakness in the caloric test. VEMP testing was performed for 16 patients. Seven (43.8%) and 8 (50.0%) patients were evaluated as abnormal in cervical VEMP and ocular VEMP testing, respectively. The rate of detection of nystagmus was significantly higher than that of subjective symptoms. As vestibular dysfunction in patients with VKH disease cannot be detected through history taking alone, nystagmus testing, caloric testing, and VEMP testing should be performed to evaluate vestibular functions associated with VKH disease. It is considered that abnormal VEMP findings are associated with otolith organ dysfunction.

Keywords:
Vogt-Koyanagi-Harada disease, Vertigo, Dizziness, Caloric test, Vestibular evoked myogenic potential
1.
Al Dousary S: Auditory and vestibular manifestations of Vogt-Koyanagi-Harada disease. J Laryngol Otol 2011;125:138-141.
2.
Curthoys IS, Vulovic V, Manzari L: Ocular vestibular-evoked myogenic potential (oVEMP) to test utricular function: neural and oculomotor evidence. Acta Otorhinolaryngol Ital 2012;32:41-45.
3.
Escobar C, Zuasti A, Ferrer C, Garcia-Ortega F: Melanocytes in the stria vascularis and vestibular labyrinth of the Mongolian gerbil (Meriones unguiculatus). Pigment Cell Res 1995;8:271-278.
4.
Fukuda T: The stepping test. Acta Otolaryngol 1959;50:95-108.
5.
Kimura H, Ohashi N, Aso S, Watanabe Y: Clinical study of the role of melanocytes in the inner ear of patients with Harada's disease. ORL J Otorhinolaryngol Relat Spec 1996;58:233-237.
6.
Kitamura M, Takami K, Kitaichi N, Namba K, Kitamei H, Kotake S, Ohno S: Comparative study of two sets of criteria for the diagnosis of Vogt-Koyanagi-Harada's disease. Am J Ophthalmol 2005;139:1080-1085.
7.
LaFerriere KA, Arenberg IK, Hawkins JE Jr, Johnsson LG: Melanocytes of the vestibular labyrinth and their relationship to the microvasculature. Ann Otol Rhinol Laryngol 1974;83:685-694.
8.
Midorikawa C, Takahashi M, Tsujita N, Hoshikawa H: A simple cold caloric test (in Japanese). Nippon Jibiinkoka Gakkai Kaiho Tokyo 1984;87:1111-1119.
9.
Morita S, Nakamaru Y, Obara N, Masuya M, Fukuda S: Characteristics and prognosis of hearing loss associated with Vogt-Koyanagi-Harada disease. Audiol Neurotol 2014;19:49-56.
10.
Noguchi Y, Nishio A, Takase H, Miyanaga M, Takahashi H, Mochizuki M, Kitamura K: Audiovestibular findings in patients with Vogt-Koyanagi-Harada disease. Acta Otolaryngol 2014;134:339-344.
11.
Ondrey FG, Moldestad E, Mastroianni MA, Pikus A, Sklare D, Vernon E, Nusenblatt R, Smith J: Sensorineural hearing loss in Vogt-Koyanagi-Harada syndrome. Laryngoscope 2006;116:1873-1876.
12.
Papathanasiou ES, Murofushi T, Akin FW, Colebatch JG: International guidelines for the clinical application of cervical vestibular evoked myogenic potentials: an expert consensus report. Clin Neurophysiol 2014;125:658-666.
13.
Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, Pivetti-Pezzi P, Tessler HH, Usui M: Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 2001;131:647-652.
14.
Silpa-Archa S, Silpa-Archa N, Preble JM, Foster CS: Vogt-Koyanagi-Harada syndrome: perspectives for immunogenetics, multimodal imaging, and therapeutic options. Autoimmun Rev 2016;15:809-819.
15.
Steel KP, Barkway C: Another role for melanocytes: their importance for normal stria vascularis development in the mammalian inner ear. Development 1989;107:453-463.
16.
Sugita S, Takase H, Taguchi C, Imai Y, Kamoi K, Kawaguchi T, Sugamoto Y, Futagami Y, Itoh K, Mochizuki M: Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens. Invest Ophthalmol Vis Sci 2006;47:2547-2554.
17.
Tahara T, Sekitani T: Neurotological evaluation of Harada's disease. Acta Otolaryngol Suppl 1995;519:110-113.
18.
Weber KP, MacDougall HG, Halmagyi GM, Curthoys IS: Impulsive testing of semicircular-canal function using video-oculography. Ann NY Acad Sci 2009;1164:486-491.
19.
Yoshimoto Y: Otoneurological observation and classification of Harada's disease presenting with aural symptoms, especially vertigo. Acta Otolaryngol Suppl 1995;519:114-117.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.